NO940598L - - Google Patents

Info

Publication number
NO940598L
NO940598L NO940598A NO940598A NO940598L NO 940598 L NO940598 L NO 940598L NO 940598 A NO940598 A NO 940598A NO 940598 A NO940598 A NO 940598A NO 940598 L NO940598 L NO 940598L
Authority
NO
Norway
Prior art keywords
sphingoglycolipid
integer
chem
isopropyl
sec
Prior art date
Application number
NO940598A
Other languages
English (en)
Norwegian (no)
Other versions
NO180338C (no
NO180338B (no
NO940598D0 (no
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO940598D0 publication Critical patent/NO940598D0/no
Publication of NO940598L publication Critical patent/NO940598L/no
Publication of NO180338B publication Critical patent/NO180338B/no
Publication of NO180338C publication Critical patent/NO180338C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO940598A 1991-08-29 1994-02-22 Glycosfingolipider, fremgangsmåte til fremstilling av slike, antitumormiddel og immunostimulator NO180338C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3244384A JPH0559081A (ja) 1991-08-29 1991-08-29 新規スフインゴ糖脂質、その製造法および使用
PCT/JP1992/000561 WO1993005055A1 (fr) 1991-08-29 1992-04-28 Nouveau sphingoglycolipide et son utilisation

Publications (4)

Publication Number Publication Date
NO940598D0 NO940598D0 (no) 1994-02-22
NO940598L true NO940598L (de) 1994-04-27
NO180338B NO180338B (no) 1996-12-23
NO180338C NO180338C (no) 1997-04-02

Family

ID=17117885

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940598A NO180338C (no) 1991-08-29 1994-02-22 Glycosfingolipider, fremgangsmåte til fremstilling av slike, antitumormiddel og immunostimulator

Country Status (18)

Country Link
EP (1) EP0609437B1 (de)
JP (2) JPH0559081A (de)
KR (1) KR100220793B1 (de)
AT (1) ATE181922T1 (de)
AU (1) AU665536B2 (de)
CA (1) CA2116442C (de)
DE (1) DE69229557T2 (de)
DK (1) DK0609437T3 (de)
ES (1) ES2134213T3 (de)
FI (1) FI105189B (de)
GR (1) GR3030723T3 (de)
HU (1) HU223839B1 (de)
NO (1) NO180338C (de)
PT (1) PT100736B (de)
SG (1) SG44031A1 (de)
TW (1) TW197446B (de)
WO (1) WO1993005055A1 (de)
ZA (1) ZA923239B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
TW261533B (de) * 1992-07-16 1995-11-01 Kirin Brewery
AU683026B2 (en) * 1992-10-22 1997-10-30 Kirin Pharma Kabushiki Kaisha Novel shingoglycolipid and use thereof
EP0694558B1 (de) * 1993-04-15 1999-01-27 Kirin Beer Kabushiki Kaisha Sphingoglycolipid und verwendung davon
TW555562B (en) 1996-12-27 2003-10-01 Kirin Brewery Method for activation of human antigen-presenting cells, activated human antigen-presenting cells and use thereof
TW575420B (en) * 1997-09-22 2004-02-11 Kirin Brewery Composition for enhancing cellular immunogenicity comprising alpha-glycosylceramides
AU782539B2 (en) * 2000-01-14 2005-08-04 Meiji Dairies Corporation Antigen-specific IgE antibody production inhibitors
JP2002030093A (ja) * 2000-03-13 2002-01-29 Nof Corp グリコシルセラミドの精製方法
EP1437358B1 (de) 2001-08-16 2006-10-18 Daiichi Asubio Pharma Co., Ltd. Neues glykolipid, und heilmittel für autoimmunerkrankungen, das dieses als wirkstoff enthält
BR0314640A (pt) * 2002-09-20 2005-08-02 Kirin Brewery Inibidor de vìrus de hepatite c compreendendo, como um ingrediente ativo, alfa-glicosilceramida
JP4585172B2 (ja) * 2003-01-31 2010-11-24 森永乳業株式会社 骨形成促進剤
ES2676345T3 (es) 2003-02-14 2018-07-18 Japan As Represented By President Of National Center Of Neurology And Psychiatry Ministry Of Health Derivados del glicolípido, proceso para su producción, intermedios para la síntesis del mismo, y proceso para la producción de los intermedios
JP4753089B2 (ja) * 2004-12-20 2011-08-17 株式会社岡安商店 体内脂肪の分解促進作用を有する組成物及びそれを含有する食品又は食品配合剤
JP2007070311A (ja) * 2005-09-09 2007-03-22 Gunma Univ α−ガラクトシルセラミドからなる感染症予防剤及び感染症治療剤
EP1776963A1 (de) 2005-10-19 2007-04-25 Gbf-Gesellschaft Für Biotechnologische Forschung Mbh Hexosylceramiden als Adjuvantien und ihre Verwendung in pharmazeutischen Zusammensetzungen
WO2008047174A1 (en) * 2006-10-18 2008-04-24 Centre National De La Recherche Scientifique Alpha-galactosylceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them
KR100868959B1 (ko) * 2006-12-30 2008-11-17 재단법인서울대학교산학협력재단 알파-갈락토실세라마이드 유도체, 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는면역보조용 약학적 조성물
US7959907B2 (en) 2007-02-21 2011-06-14 Vib Vzw Method of treating cancer by combination therapy using TNF and alpha-galactosylceramide
JP4995172B2 (ja) * 2008-10-10 2012-08-08 壽製薬株式会社 糖脂質誘導体、その製造方法並びにそれを有効成分とする医薬
JP5719783B2 (ja) 2009-02-16 2015-05-20 セレニス セラピューティクス ホールディング エスアー アポリポタンパクa−i模倣物
JP5095683B2 (ja) * 2009-07-06 2012-12-12 壽製薬株式会社 新規糖脂質誘導体及びこれを有効成分とする製剤
JP5025692B2 (ja) * 2009-07-06 2012-09-12 壽製薬株式会社 糖脂質誘導体の製造方法
JP2010254718A (ja) * 2010-08-13 2010-11-11 Morinaga Milk Ind Co Ltd 骨形成促進剤
SG189019A1 (en) 2010-10-18 2013-05-31 Cerenis Therapeutics Holding Sa Compounds, compositions and methods useful for cholesterol mobilisation
WO2012074116A1 (ja) 2010-12-02 2012-06-07 独立行政法人理化学研究所 アロNKT細胞を用いた免疫療法およびそのためのT細胞抗原受容体(TCR)遺伝子のα鎖領域が均一なVα-Jαに再構成されている細胞および該細胞由来NKT細胞のバンキング
WO2014021464A1 (ja) * 2012-08-03 2014-02-06 独立行政法人理化学研究所 水酸化krn7000類縁体及びその用途
WO2014053482A1 (en) 2012-10-03 2014-04-10 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza with invariant nkt cell agonists
PL2923208T3 (pl) 2012-11-21 2019-09-30 Institut National De La Santé Et De La Recherche Médicale (Inserm) Sposoby określania ryzyka ostrej choroby przeszczep przeciwko gospodarzowi
WO2017207040A1 (en) 2016-06-01 2017-12-07 Vib Vzw ANTI-CANCER THERAPY USING A LEPTIN ANTAGONIST AND AN iNKT-CELL ACTIVATOR
KR102328367B1 (ko) * 2019-11-05 2021-11-18 한국해양과학기술원 아젤록심 d를 유효성분으로 함유하는 방사선 민감성 증진용 조성물
CN116528839A (zh) 2020-12-04 2023-08-01 瑞格国际生技股份有限公司 药代动力学被改善的含CD1d配体化合物的脂质体制剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6157594A (ja) * 1984-08-30 1986-03-24 Suntory Ltd ガラクトスフインゴ脂質及びその製造法
JP2588729B2 (ja) * 1987-10-05 1997-03-12 塩野義製薬株式会社 スフィンゴシン誘導体
DE3840044A1 (de) * 1988-11-27 1990-06-07 Behringwerke Ag Glykosphingolipide mit kopplungsfaehiger gruppe im sphingoidanteil, ihre herstellung und verwendung
JP3068910B2 (ja) * 1990-11-08 2000-07-24 麒麟麦酒株式会社 新規スフィンゴ糖脂質、その製造法および使用

Also Published As

Publication number Publication date
AU665536B2 (en) 1996-01-11
CA2116442A1 (en) 1993-03-18
HK1009967A1 (en) 1999-09-17
HU9400596D0 (en) 1994-05-30
CA2116442C (en) 2000-09-05
DK0609437T3 (da) 2000-01-31
EP0609437A4 (en) 1994-08-24
DE69229557D1 (de) 1999-08-12
ZA923239B (en) 1993-05-05
EP0609437A1 (de) 1994-08-10
EP0609437B1 (de) 1999-07-07
JP2774194B2 (ja) 1998-07-09
NO180338C (no) 1997-04-02
AU1666492A (en) 1993-04-05
NO180338B (no) 1996-12-23
HUT70435A (en) 1995-10-30
GR3030723T3 (en) 1999-11-30
TW197446B (de) 1993-01-01
JPH0559081A (ja) 1993-03-09
DE69229557T2 (de) 1999-11-25
WO1993005055A1 (fr) 1993-03-18
HU223839B1 (hu) 2005-02-28
FI940851A7 (fi) 1994-02-23
ES2134213T3 (es) 1999-10-01
FI105189B (fi) 2000-06-30
FI940851A0 (fi) 1994-02-23
PT100736B (pt) 1999-04-30
NO940598D0 (no) 1994-02-22
KR100220793B1 (ko) 1999-10-01
SG44031A1 (en) 1997-11-14
ATE181922T1 (de) 1999-07-15
PT100736A (pt) 1993-09-30

Similar Documents

Publication Publication Date Title
TW197446B (de)
AU689391B2 (en) Cyclic peptide antifungal agents and process for preparation thereof
AU613805B2 (en) Pyrimidinedione derivative compounds, method of producing the same and antiarrythmic agents containing the same
CA2043071A1 (en) Heterocyclic compounds
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
SG49607A1 (en) 1-methylcarbapenem derivatives and process for preparation thereof
ZA898678B (en) Compositions and compounds
HUT59139A (en) Process for producing tricyclic compounds and antimicrobial pharmaceutical compositions comprising same
PH18498A (en) Novel cephalosporin compounds,pharmaceutical compositions containing same and method of treatment thereof
HUT50337A (en) Process for producing benzoxazine derivatives and pharmaceutical compositions comprising the compounds
EP0347815A3 (en) Cleaner for thermostatic water bath
HUT54372A (en) Process for producing macrolide compounds and pharmaceutical compositions containing them as active components
EP0573977A3 (en) Novel estradiol derivative-chlorambucil conjugate, process for preparing the same, and pharmaceutical composition
TW350757B (en) Benzisoxazole derivatives and pesticidal compositions containing them
EP0462948A3 (en) Pharmaceutical compositions comprising 3-amino-epsilon-caprolactames for enhancing learning and memory
HUT48259A (en) Herbicide compositions containing new macrolide active components, and process for producing new macrolide compounds and pharmaceutical compositions containing them as active components
MY109729A (en) Benzofuranylimidazole derivatives, a process for the preparation and therapeutical compositions containing the same
GR3027627T3 (en) New 17alpha-Cyanomethylestra-4,9-dien-derivatives, a process for the production of these compounds and pharmaceutical compositions containing them
HUT65417A (en) Process for producing pharmaceutical compositions for rectal administration containing triazole derivatives
EP0273357A3 (en) Fluorine-containing macrolide compounds, pharmaceutical compositions comprising the same and their use for the manufacture of medicaments

Legal Events

Date Code Title Description
MK1K Patent expired